Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

BSE Index Services, an arm of stock exchange BSE, on Wednesday announced the launch of defence index to track the performance ...

Q2 2025 Earnings Call Transcript August 12, 2025 Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is ...

Q2 2025 Earnings Call Transcript August 12, 2025 BioRestorative Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.41. Operator: Greetings. Welcome to the ...